These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6324161)
1. [Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)]. Jacquillat C; Khayat D; Maral J Presse Med; 1984 Mar; 13(13):838-40. PubMed ID: 6324161 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats. Johnson DE; Thompson B Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060 [TBL] [Abstract][Full Text] [Related]
3. In vitro models for the study of combination antibiotic therapy in neutropenic patients. Zinner SH; Dudley M; Blaser J Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526 [TBL] [Abstract][Full Text] [Related]
4. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients. D'Antonio D; di Girolamo A; Iacone A; Fioritoni G; Angelini A; Dragani A; Betti S; Dell'Isola M; Piccolomini R J Chemother; 1989 Dec; 1(6):407-12. PubMed ID: 2693624 [TBL] [Abstract][Full Text] [Related]
6. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027 [TBL] [Abstract][Full Text] [Related]
7. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517 [TBL] [Abstract][Full Text] [Related]
9. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients. Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer. Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805 [TBL] [Abstract][Full Text] [Related]
11. Treatment of severe infections in patients with cancer. The role of new acyl-penicillins. Klastersky J Arch Intern Med; 1982 Oct; 142(11):1984-7. PubMed ID: 6215007 [TBL] [Abstract][Full Text] [Related]
12. Empiric antibiotic therapy for granulocytopenic cancer patients. Schimpff SC Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study. Kosmidis H; Varvoutsi M; Kafetzis D; Koupari G; Bouhoutsou D; Papadatos C Chemioterapia; 1987 Jun; 6(2 Suppl):396-8. PubMed ID: 3334581 [No Abstract] [Full Text] [Related]
14. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin]. Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439 [TBL] [Abstract][Full Text] [Related]
16. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)]. Petit JC; Richard G; Burghoffer B; Daguet GL Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286 [TBL] [Abstract][Full Text] [Related]
17. Gram-positive bacteraemia in granulocytopenic cancer patients. EORTC International Antimicrobial Therapy Cooperative Group Eur J Cancer; 1990; 26(5):569-74. PubMed ID: 2144743 [TBL] [Abstract][Full Text] [Related]
18. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Peterson LR; Gerding DN; Moody JA; Fasching CE Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087 [TBL] [Abstract][Full Text] [Related]
19. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]. Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935 [TBL] [Abstract][Full Text] [Related]
20. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients. Croydon E; Weerts D Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585 [No Abstract] [Full Text] [Related] [Next] [New Search]